TDRKH Antikörper (AA 36-355)

Produktnummer ABIN6148980

Produktdetails anti-TDRKH Antikörper

Target: TDRKH (Tudor and KH Domain Containing (TDRKH))

Bindungsspezifität: AA 36-355

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TDRKH Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: RYRESREERL TFVGEDDIEI EMRVPQEAVK LIIGRQGANI KQLRKQTGAR IDVDTEDVGD ERVLLISGFP VQVCKAKAAI HQILTENTPV SEQLSVPQRS VGRIIGRGGE TIRSICKASG AKITCDKESE GTLLLSRLIK ISGTQKEVAA AKHLILEKVS EDEELRKRIA HSAETRVPRK QPISVRREDM TEPGGAGEPA LWKNTSSSME PTAPLVTPPP KGGGDMAVVV SKEGSWEKPS DDSFQKSEAQ AIPEMPMFEI PSPDFSFHAD EYLEVYVSAS EHPNHFWIQI VGSRSLQLDK LVNEMTQHYE NSVPEDLTVH

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Polyclonal Antibodies

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 36-355 of human TDRKH (NP_001077432.1).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000

Kommentare:

HIGH QUALITY

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu TDRKH

Target: TDRKH (Tudor and KH Domain Containing (TDRKH))

Andere Bezeichnung: TDRKH (TDRKH Produkte)

Synonyme: RGD1311196 antikoerper, tdrd2 antikoerper, MGC85144 antikoerper, TDRD2 antikoerper, 2700091C21Rik antikoerper, Tdrd2 antikoerper, tudor and KH domain containing antikoerper, tudor and KH domain containing L homeolog antikoerper, tudor and KH domain containing protein antikoerper, Tdrkh antikoerper, TDRKH antikoerper, tdrkh.L antikoerper, tdrkh antikoerper

Hintergrund: Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.,TDRKH,TDRD2,Epigenetics & Nuclear Signaling,Cell Biology & Developmental Biology,TDRKH

Molekulargewicht: 57 kDa/62 kDa

Gen-ID: 11022

UniProt: Q9Y2W6